Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Increases By 390.5%

iSpecimen Inc. (NASDAQ:ISPC) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 41,200 shares, an increase of 390.5% from the October 15th total of 8,400 shares. Approximately 5.4% of the company’s stock are sold short. Based on an average daily trading volume, of 395,600 shares, the days-to-cover ratio is currently 0.1 days.

iSpecimen Trading Down 0.9 %

NASDAQ:ISPC traded down $0.04 during midday trading on Tuesday, reaching $4.48. The company had a trading volume of 104,297 shares, compared to its average volume of 194,645. The stock’s fifty day simple moving average is $3.93 and its 200-day simple moving average is $1.58. iSpecimen has a 12-month low of $3.41 and a 12-month high of $12.80. The firm has a market capitalization of $3.72 million, a price-to-earnings ratio of -0.24 and a beta of 1.59.

About iSpecimen

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.